Response by Zhang et al to Letter Regarding Article, “Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19”

Author:

Zhang Peng123,Zhu Lihua13,Cai Jingjing4,Lei Fang3,Qin Juan-Juan13,Wang Yibin5,Yuan Yufeng6,Loomba Rohit7,Liu Peter P.8,Li Hongliang123ORCID

Affiliation:

1. From the Department of Cardiology, Renmin Hospital of Wuhan University, China (P.Z., L.Z., J.-J.Q., H.L.)

2. Medical Science Research Center (P.Z., H.L.)

3. Institute of Model Animal of Wuhan University, China (P.Z., L.Z., F.L., J.-J.Q., H.L.)

4. Department of Cardiology, The Third Xiangya Hospital, Central South University, Changsha, China (J.C.)

5. Department of Anesthesiology, Cardiovascular Research Laboratories, David Geffen School of Medicine, University of California, Los Angeles (Y.W.)

6. Department of Hepatobiliary and Pancreatic Surgery (Y.Y.), Zhongnan Hospital of Wuhan University, China

7. NAFLD Research Center, Division of Gastroenterology and Epidemiology, University of California San Diego (R.L.)

8. Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, ON, Canada (P.P.L.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology

Reference4 articles.

1. Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19

2. Status of Hypertension in China

3. Covid-19 testing, hospital admission, and intensive care among 2,026,227 United States veterans aged 54-75 years.;Rentsch CT;medRxiv,2020

4. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area [published online April 22, 2020].;Richardson S;JAMA

Cited by 60 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3